## Abstract ## BACKGROUND. This prospective study was undertaken to evaluate patient and treatment characteristics that contribute to hematologic toxicity in older cancer patients. ## METHODS. A nationwide study of 115 community oncology practices was conducted between 2002 and 2005 with data co
Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy
β Scribed by Michelle Shayne; Eva Culakova; Debra Wolff; Marek S. Poniewierski; David C. Dale; Jeffrey Crawford; Gary H. Lyman
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 234 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Using a cohort of macroscopic curative resections of gastric cancer at stages 11, Ill, and IV, a randomized controlled trial was performed to clucidate the dose efficacy of intensive adjuvant cancer chemotherapy with mitomycin C. Between June 1983 and December 1986, 336 patients with gastric cancer
A retrospective study was done to evaluate the frequency and severity of wound complications in 112 patients with breast cancer who received adjuvant chemotherapy following mastectomy with immediate breast reconstruction. Data on wound complications were available for 120 mastectomies. The rate of c